The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 721,576 share decrease in total short interest for SciClone Pharmaceuticals, Inc. (SCLN), to 846,255, a decrease of 46.02% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for SCLN at the 06/15/2017 settlement increased to 1,493,546, as compared to 256,337 at the 05/31/2017 report. That brought "days to cover" down to 1.00, a 83.65% decrease from the 6.12 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for SCLN at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where SCLN had been shorted as a hedge. The chart below shows the one year performance of SCLN shares, versus its 200 day moving average. Looking at this chart, SCLN's low point in its 52 week range is $8.55 per share, with $13.73 as the 52 week high point — that compares with a last trade of $10.90.
More from Stocks
White House Trade Official Boasts Trade Deal as 'Huge' for Farmers
Peter Navarro tells the White House-friendly 'Fox and Friends' show that the deal will be a 'boom in farm country.'
Market Wrap: GM Addresses New Offer Directly to Striking Workers
The autoworkers strike could cost GM up to $1.5 billion, according to a Credit Suisse note.
U.S.-China 'Mini Deal' Removes Key Distraction for Markets
The "mini-deal' announced Friday drew immidiate scorn, but it removes an important distraction for the markets ahead of earnings season.